Dicerna Pharmaceuticals, Inc.
Methods for treating hepatitis B infection
Last updated:
Abstract:
This application relates to potent oligonucleotides useful for reducing HBsAg expression and treating HBV infections.
Status:
Grant
Type:
Utility
Filling date:
12 May 2021
Issue date:
15 Mar 2022